[18F]Fluorodeoxyglucose-positron emission tomography screening for lung cancer: a systematic review and meta-analysis
Open Access
- 1 January 2013
- journal article
- research article
- Published by E-MED LTD in Cancer Imaging
- Vol. 13 (4) , 458-465
Abstract
Although low-dose computed tomography (CT) is a recommended modality for lung cancer screening in high-risk populations, the role of other modalities, such as [(18)F]fluorodeoxyglucose-positron emission tomography (PET), is unclear. We conducted a systematic review to describe the role of PET in lung cancer screening. A systematic review was conducted by reviewing primary studies focusing on PET screening for lung cancer until July 2012. Two independent reviewers identified studies that were compatible for inclusion/exclusion criteria. The analysis was restricted to English and included studies published since 2000. A descriptive analysis was used to summarize the results, and the pooled diagnostic performance of selective PET screening was calculated by weighted average using individual sample sizes. Among the identified studies (n = 3497), 12 studies were included for analysis. None of the studies evaluated the efficacy of primary PET screening specific to lung cancer. Eight studies focused on primary PET screening for all types of cancer; the detection rates of lung cancer were low. Four studies reported evidence of lung cancer screening programs with selective PET, in which the estimated pooled sensitivity and specificity was 83% and 91%, respectively. The role of primary PET screening for lung cancer remains unknown. However, PET has high sensitivity and specificity as a selective screening modality. Further studies must be conducted to evaluate the use of PET or PET/computed tomography screening for high-risk populations, preferably using randomized trials or prospective registration. Our meta-analysis indicates that PET has high sensitivity and specificity as a selective screening modality.Keywords
This publication has 33 references indexed in Scilit:
- The value of positron emission tomography in early detection of lung cancer in high‐risk population: a systematic reviewThe Clinical Respiratory Journal, 2012
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- Correlation of 18F-fluorodeoxyglucose uptake on positron emission tomography with Ki-67 index and pathological invasive area in lung adenocarcinomas 30mm or less in sizeEuropean Journal of Radiology, 2010
- Primary Tumor Standardized Uptake Value Measured on Fluorodeoxyglucose Positron Emission Tomography Is of Prognostic Value for Survival in Non-small Cell Lung Cancer: Update of a Systematic Review and Meta-Analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging ProjectJournal of Thoracic Oncology, 2010
- Lung Cancer: Morphological and Functional Approach to Screening, Staging and Treatment PlanningFuture Oncology, 2010
- Staging of Non–Small Cell Lung Cancer Using Integrated PET/CTAmerican Journal of Roentgenology, 2009
- The Use of Positron Emission Tomography (PET) in the Staging/Evaluation, Treatment, and Follow-Up of Patients With Lung Cancer: A Critical ReviewInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Solitary Pulmonary Nodules: Meta-analytic Comparison of Cross-sectional Imaging Modalities for Diagnosis of MalignancyRadiology, 2008
- Population screening for lung cancer using computed tomography, is there evidence of clinical effectiveness? A systematic review of the literatureThorax, 2007
- Screening for cancer with PET and PET/CT: potential and limitations.2007